CSTM
NEUTRAL
$31.38
Live
Constellium SE · NYSE
Target $31.43
(+0.2%)
$9.07
52W Range
$31.5
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 25, 2026
Market cap
$4.27B
P/E
16.34
ROE
32.4%
Profit margin
3.2%
Debt/Equity
2.12
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
80%
CSTM presents a dichotomy between explosive growth and deteriorating fundamental value. While the Piotroski F-Score of 4/9 indicates stable but mediocre financial health, the stock is trading at a significant premium to its Graham Number ($17.43) and Intrinsic Value ($13.44). Despite a very attractive PEG ratio of 0.40 and strong ROE of 32.39%, the combination of aggressive insider selling by the CEO and CFO and a high Debt/Equity ratio (2.12) suggests the current price may be overextended.
Key Strengths
Exceptional ROE of 32.39% significantly outperforming sector averages
Strong revenue growth (27.90% YoY and 40.53% Q/Q)
Very low PEG ratio (0.40) suggesting growth is not yet fully priced in relative to earnings
Massive 1-year price appreciation (+234.2%)
Consistent recent earnings beats with high average surprise (31.34%)
Key Risks
Significant valuation gap: Current price ($31.38) is >130% above intrinsic value
Bearish insider sentiment with selling from both CEO and CFO
High leverage with a Debt/Equity ratio of 2.12, double the sector average
Poor liquidity indicated by a Quick Ratio of 0.47
High volatility in quarterly earnings track record
AI Fair Value Estimate
Based on comprehensive analysis
$20.44
-34.9% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
47
Moderate
30
85
75
45
0
AI Verdict
Speculative Growth
Key drivers: High Revenue/EPS Growth, Overvaluation relative to Graham/Intrinsic, Insider Selling, High Leverage
Confidence
85%
Value
30/100
Trading at a steep premium to defensive fair value metrics.
Positives
- Low P/S ratio (0.51)
- Low PEG ratio (0.40)
Watchpoints
- Price far exceeds Graham Number ($17.43)
- Price far exceeds Intrinsic Value ($13.44)
- High Price/Book (4.46)
Future
85/100
Growth metrics are the primary driver of the current bull run.
Positives
- Strong YoY Revenue growth (27.9%)
- Explosive YoY EPS growth (312.5%)
- Positive analyst target price ($31.43)
Watchpoints
- Commodity sector cyclicality
Past
75/100
Strong momentum and recovery over the last 12 months.
Positives
- Strong 1Y, 3Y, and 5Y price returns
- Recent trend of beating earnings estimates
Watchpoints
- Historical earnings volatility
Health
45/100
Financial health is strained by high leverage and mediocre F-Score.
Positives
- Current Ratio > 1.0
Watchpoints
- Piotroski F-Score of 4/9 (Stable/Weak)
- High Debt/Equity (2.12)
- Low Quick Ratio (0.47)
Dividend
0/100
Company is not returning capital to shareholders.
Positives
No standout positives identified.
Watchpoints
- No dividend payments
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$31.38
Analyst Target
$31.43
Upside/Downside
+0.2%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for CSTM and closest competitors.
Updated 2026-04-24
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
CSTM
Constellium SE
Primary
|
+91.8% | +130.7% | +234.2% | +85.7% | +23.0% | +6.1% |
|
EMAT
Evolution Metals & Technologies Corp.
Peer
|
-60.1% | -60.1% | -60.1% | -60.1% | -7.2% | -7.9% |
|
CBT
Cabot Corporation
Peer
|
+53.6% | +14.8% | -0.9% | +9.1% | +5.7% | +3.2% |
|
CC
The Chemours Company
Peer
|
+1.1% | +8.1% | +119.6% | +91.7% | +28.1% | +14.8% |
|
ALM
Almonty Industries Inc.
Peer
|
+749.7% | +1577.8% | +399.8% | +264.3% | +31.4% | -20.2% |
CST
Constellium SE
Primary
5Y
+91.8%
3Y
+130.7%
1Y
+234.2%
6M
+85.7%
1M
+23.0%
1W
+6.1%
EMA
Evolution Metals & Technologies Corp.
Peer
5Y
-60.1%
3Y
-60.1%
1Y
-60.1%
6M
-60.1%
1M
-7.2%
1W
-7.9%
CBT
Cabot Corporation
Peer
5Y
+53.6%
3Y
+14.8%
1Y
-0.9%
6M
+9.1%
1M
+5.7%
1W
+3.2%
CC
The Chemours Company
Peer
5Y
+1.1%
3Y
+8.1%
1Y
+119.6%
6M
+91.7%
1M
+28.1%
1W
+14.8%
ALM
Almonty Industries Inc.
Peer
5Y
+749.7%
3Y
+1577.8%
1Y
+399.8%
6M
+264.3%
1M
+31.4%
1W
-20.2%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
16.34
Forward P/E
13.72
PEG Ratio
0.4
P/B Ratio
4.46
P/S Ratio
0.51
EV/Revenue
0.73
EV/EBITDA
7.64
Market Cap
$4.27B
Profitability
Profit margins and return metrics
Profit Margin
3.23%
Operating Margin
7.18%
Gross Margin
14.33%
ROE
32.39%
ROA
5.96%
Growth
Revenue and earnings growth rates
Revenue Growth
+27.9%
Earnings Growth
N/A
Q/Q Revenue Growth
+40.53%
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
2.12
High debt
Current Ratio
1.29
Good
Quick Ratio
0.47
Poor
Cash/Share
$0.89
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$2.2B
Gross Margin
15.8%
Op. Margin
7.5%
Net Margin
5.1%
Total Assets
$5.4B
Liabilities
$4.4B
Equity
$1.0B
Debt/Equity
4.60x
Operating CF
$0.2B
CapEx
$-0.1B
Free Cash Flow
$0.1B
FCF Yield
50%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-04-29
$N/A
2026-02-18
$0.68
+110.5% surprise
2025-10-29
$0.48
+51.5% surprise
2025-07-29
$0.09
-68.0% surprise
Basic Materials Sector Comparison
Comparing CSTM against 111 companies in the Basic Materials sector
(5 bullish, 42 neutral, 64 bearish)
P/E Ratio
16.34
This Stock
vs
37.28
Sector Avg
-56.2%
(Discount)
Return on Equity (ROE)
32.39%
This Stock
vs
-9.77%
Sector Avg
-431.6%
(Below Avg)
Profit Margin
3.23%
This Stock
vs
-7.52%
Sector Avg
-142.9%
(Weaker)
Debt to Equity
2.12
This Stock
vs
1.03
Sector Avg
+107.2%
(Higher)
Revenue Growth
27.9%
This Stock
vs
37.79%
Sector Avg
-26.2%
(Slower)
Current Ratio
1.29
This Stock
vs
5.84
Sector Avg
-77.9%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
CSTM
Constellium SE
|
NEUTRAL | $4.27B | 16.34 | 32.4% | 3.2% | $31.38 | |
|
EMAT
Evolution Metals &...
|
BEARISH | $4.5B | - | -% | -% | $7.58 | Compare |
|
CBT
Cabot Corporation
|
NEUTRAL | $4.01B | 13.44 | 21.8% | 8.6% | $76.85 | Compare |
|
CC
The Chemours Company
|
BEARISH | $3.99B | - | -93.8% | -6.6% | $26.61 | Compare |
|
ALM
Almonty Industries Inc.
|
BEARISH | $4.56B | - | -57.3% | -216.3% | $17.78 | Compare |
CSTM
Constellium SE
NEUTRAL
Mkt Cap
$4.3B
P/E
16.3
ROE
32.4%
Price
$31.38
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | BECKER MARCUS | Officer | Sale | 10,000 | $250,900 |
| 2026-03-12 | WALTERS STEPHEN CHARLES | General Counsel | Stock Award | 5,834 | - |
| 2026-03-12 | PERKINS MATTHEW B. | Officer | Stock Award | 10,210 | - |
| 2026-03-12 | BRUN NICOLAS | Officer | Stock Award | 4,376 | - |
| 2026-03-12 | CORRE STEPHANE | President | Stock Award | 7,293 | - |
| 2026-03-12 | WEILER WIEBKE | Director | Stock Award | 625 | - |
| 2026-03-12 | GUO JACK Q. | Chief Financial Officer | Stock Award | 19,690 | - |
| 2026-03-12 | HOFFMANN PHILIPPE | Officer | Stock Award | 12,033 | - |
| 2026-03-12 | JOERG INGRID | Chief Executive Officer | Stock Award | 31,358 | - |
| 2026-03-12 | JURKOVIC PHILIP RYAN | Officer | Stock Award | 10,210 | - |
| 2026-03-12 | BECKER MARCUS | Officer | Stock Award | 3,938 | - |
| 2026-03-12 | SCHILD NIKLAUS | Chief Technology Officer | Stock Award | 3,355 | - |
| 2026-03-12 | PIQUIER LUDOVIC | Chief Technology Officer | Stock Award | 5,469 | - |
| 2026-03-10 | CORRE STEPHANE | Officer | Sale | 1,500 | $38,835 |
| 2026-03-10 | GUO JACK Q. | Chief Financial Officer | Sale | 41,717 | $1,079,219 |
BECKER MARCUS
Officer
2026-03-16
10,000 shares
·
$250,900
WALTERS STEPHEN CHARLES
General Counsel
2026-03-12
5,834 shares
PERKINS MATTHEW B.
Officer
2026-03-12
10,210 shares
BRUN NICOLAS
Officer
2026-03-12
4,376 shares
CORRE STEPHANE
President
2026-03-12
7,293 shares
WEILER WIEBKE
Director
2026-03-12
625 shares
GUO JACK Q.
Chief Financial Officer
2026-03-12
19,690 shares
HOFFMANN PHILIPPE
Officer
2026-03-12
12,033 shares
JOERG INGRID
Chief Executive Officer
2026-03-12
31,358 shares
JURKOVIC PHILIP RYAN
Officer
2026-03-12
10,210 shares
BECKER MARCUS
Officer
2026-03-12
3,938 shares
SCHILD NIKLAUS
Chief Technology Officer
2026-03-12
3,355 shares
PIQUIER LUDOVIC
Chief Technology Officer
2026-03-12
5,469 shares
CORRE STEPHANE
Officer
2026-03-10
1,500 shares
·
$38,835
GUO JACK Q.
Chief Financial Officer
2026-03-10
41,717 shares
·
$1,079,219
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
STRONG_BUY
4 analysts
JP Morgan
2026-04-16
Overweight
Overweight
Wells Fargo
2026-04-16
Overweight
Overweight
JP Morgan
2026-02-19
Overweight
Overweight
Wells Fargo
2026-02-19
Overweight
Overweight
Deutsche Bank
2026-02-19
Buy
Buy
BMO Capital
2026-02-19
Outperform
Outperform
Wells Fargo
2026-01-13
Equal-Weight
Overweight
JP Morgan
2025-10-30
Overweight
Overweight
Wells Fargo
2025-10-30
Equal-Weight
Equal-Weight
Past News Coverage
Recent headlines mentioning CSTM from our newsroom.
Newest → oldest
No matching news yet.